145 related articles for article (PubMed ID: 30012834)
1. Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells.
Ghosh S; Scozzaro S; Ramos AR; Delcambre S; Chevalier C; Krejci P; Erneux C
J Cell Sci; 2018 Aug; 131(16):. PubMed ID: 30012834
[TBL] [Abstract][Full Text] [Related]
2. SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cells.
Elong Edimo W; Ghosh S; Derua R; Janssens V; Waelkens E; Vanderwinden JM; Robe P; Erneux C
J Cell Sci; 2016 Mar; 129(6):1101-14. PubMed ID: 26826186
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update.
Ramos AR; Ghosh S; Suhel T; Chevalier C; Obeng EO; Fafilek B; Krejci P; Beck B; Erneux C
Adv Biol Regul; 2020 Jan; 75():100660. PubMed ID: 31628071
[TBL] [Abstract][Full Text] [Related]
4. Fibroblasts derived from patients with opsismodysplasia display SHIP2-specific cell migration and adhesion defects.
Ghosh S; Huber C; Siour Q; Sousa SB; Wright M; Cormier-Daire V; Erneux C
Hum Mutat; 2017 Dec; 38(12):1731-1739. PubMed ID: 28869677
[TBL] [Abstract][Full Text] [Related]
5. Lipid phosphatases SKIP and SHIP2 regulate fibronectin-dependent cell migration in glioblastoma.
Ramos AR; Ghosh S; Dedobbeleer M; Robe PA; Rogister B; Erneux C
FEBS J; 2019 Mar; 286(6):1120-1135. PubMed ID: 30695232
[TBL] [Abstract][Full Text] [Related]
6. Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.
Hoekstra E; Das AM; Willemsen M; Swets M; Kuppen PJ; van der Woude CJ; Bruno MJ; Shah JP; Ten Hagen TL; Chisholm JD; Kerr WG; Peppelenbosch MP; Fuhler GM
Oncotarget; 2016 Nov; 7(45):73525-73540. PubMed ID: 27716613
[TBL] [Abstract][Full Text] [Related]
7. SHIP2 phosphoinositol phosphatase positively regulates EGFR-Akt pathway, CXCR4 expression, and cell migration in MDA-MB-231 breast cancer cells.
Prasad NK
Int J Oncol; 2009 Jan; 34(1):97-105. PubMed ID: 19082482
[TBL] [Abstract][Full Text] [Related]
8. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation.
Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL
Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135
[TBL] [Abstract][Full Text] [Related]
9. Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's disease.
Lim JW; Kim SK; Choi SY; Kim DH; Gadhe CG; Lee HN; Kim HJ; Kim J; Cho SJ; Hwang H; Seong J; Jeong KS; Lee JY; Lim SM; Lee JW; Pae AN
Eur J Med Chem; 2018 Sep; 157():405-422. PubMed ID: 30103190
[TBL] [Abstract][Full Text] [Related]
10. 5'-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion.
Rajadurai CV; Havrylov S; Coelho PP; Ratcliffe CD; Zaoui K; Huang BH; Monast A; Chughtai N; Sangwan V; Gertler FB; Siegel PM; Park M
J Cell Biol; 2016 Sep; 214(6):719-34. PubMed ID: 27597754
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
12. IRSp53 is a novel interactor of SHIP2: A role of the actin binding protein Mena in their cellular localization in breast cancer cells.
Antoine M; Vandenbroere I; Ghosh S; Erneux C; Pirson I
Cell Signal; 2020 Sep; 73():109692. PubMed ID: 32535200
[TBL] [Abstract][Full Text] [Related]
13. The SHIP2 interactor Myo1c is required for cell migration in 1321 N1 glioblastoma cells.
Edimo WE; Ramos AR; Ghosh S; Vanderwinden JM; Erneux C
Biochem Biophys Res Commun; 2016 Aug; 476(4):508-514. PubMed ID: 27246739
[TBL] [Abstract][Full Text] [Related]
14. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
15. PI(3,4)P
Fukumoto M; Ijuin T; Takenawa T
Cancer Sci; 2017 May; 108(5):941-951. PubMed ID: 28247964
[TBL] [Abstract][Full Text] [Related]
16. The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.
Mercurio FA; Di Natale C; Pirone L; Iannitti R; Marasco D; Pedone EM; Palumbo R; Leone M
Sci Rep; 2017 Dec; 7(1):17474. PubMed ID: 29234063
[TBL] [Abstract][Full Text] [Related]
17. MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.
Young AI; Law AM; Castillo L; Chong S; Cullen HD; Koehler M; Herzog S; Brummer T; Lee EF; Fairlie WD; Lucas MC; Herrmann D; Allam A; Timpson P; Watkins DN; Millar EK; O'Toole SA; Gallego-Ortega D; Ormandy CJ; Oakes SR
Breast Cancer Res; 2016 Dec; 18(1):125. PubMed ID: 27931239
[TBL] [Abstract][Full Text] [Related]
18. IQGAP2 Inhibits Migration and Invasion of Gastric Cancer Cells via Elevating SHIP2 Phosphatase Activity.
Xu L; Shao Y; Ren L; Liu X; Li Y; Xu J; Ye Y
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183047
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo.
Sun Y; Wang X; Zhou Q; Lu Y; Zhang H; Chen Q; Zhao M; Su S
Oncol Rep; 2015 Jan; 33(1):338-46. PubMed ID: 25370743
[TBL] [Abstract][Full Text] [Related]
20. The β 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line.
Rivero EM; Piñero CP; Gargiulo L; Entschladen F; Zänker K; Bruzzone A; Lüthy IA
Curr Cancer Drug Targets; 2017; 17(8):756-766. PubMed ID: 28359245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
